NASDAQ:BCRX

Biocryst Pharmaceuticals Stock Predictions

etoro logo Buy BCRX
*Your capital is at risk
$8.25
-0.0900 (-1.08%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BCRX Prediction Chart

BCRX Predictions History

Latest community submissions for BCRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 7, 2025 $8.57 -1.87% $8.72 V 98.24% 1
Feb 7, 2025 $8.63 -1.17% $8.72 V 98.95% 2
Feb 7, 2025 $9.00 +3.09% $8.72 X 96.79% 0
Aug 12, 2024 $7.81 +2.31% $7.73 V 99.02% 2
Aug 12, 2024 $7.52 -1.44% $7.73 X 97.28% 0
JS JS Pro
Aug 12, 2024 $7.62 -0.13% $7.73 X 98.58% 1
JS JS Pro
Mar 29, 2022 $16.32 +0.68% $17.11 V 95.38% 1
Mar 29, 2022 Bullish $17.11 V 1
Banti Gullapalli Banti Gullapalli @BantiGullapalli.247971
Jul 13, 2021 Bearish $15.87 X 0
JS JS Pro
Feb 3, 2021 $10.06 -2.33% $10.30 X 97.67% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BCRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOCRYST PHARMACEUTICALS
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE